🚨 Coming Soon! 🚨
Prof. Nicolas Girard is joining us at #ELCC2026, to review the latest data on oncogene-addicted #NSCLC
Make sure you FOLLOW us to see his update! 🎬
🤝Endorsed by @lungcancereurope.bsky.social
Supported by an Independent Educational Grant from Bayer
#MedicalEducation #MedSky
Personalised treatment in childhood cancer: A journey through #NTRK fusion testing
📹 Video for patients & families - please share
See full video: cor2ed.com/precision-on...
Supported by an Independent Educational Grant from Bayer
#meded #moleculartesting #pediatriconcology
Upcoming webinar: ‘The evolving TROP2-directed ADC landscape in metastatic #NSCLC: strategies to optimise the treatment experience’
🗓️11th May 26
🕜11:30 EDT/16:30 BST/17:30 CEST
Register engage.cor2ed.com/events/the-e...
Supported by an Independent Educational Grant from AstraZeneca. For HCPs only
Pre-analytical phase challenges & biomarker testing in HER2+ metastatic breast cancer
From Prof. Gary Tse, Dr Carlos Barrios, & @oncbrothers.bsky.social
🎬 Watch full video: cor2ed.com/precision-on...
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd
Personalised treatment in childhood cancer: A journey through #NTRK fusion testing
🎬 Video for patients & families - please share
See the full video: cor2ed.com/precision-on...
Supported by an Independent Educational Grant from Bayer
#meded #moleculartesting #precisiononcology #MedSky
Pre-analytical phase challenges and biomarker testing in HER2+ metastatic #breastcancer
📹 Full conversation: cor2ed.com/precision-on...
Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
#MedEd #MedSky
▶️ Neurological symptoms of hypophosphatasia: unifyrare.com/en/closing-t...
Programme initiated and funded by Alexion, AstraZeneca Rare Disease. Brought to you by COR2ED Medical Affairs. Intended for healthcare professionals only. M/GL/Med HPP/0101 | Dec 2025
We're proud to share that more than 50k HCPs now follow us online!🎉
>25k YouTube subscribers
>25k social media followers
Follow us for engaging #medicaleducation developed by renowned medical experts & endorsed by Medical Societies & Patient Advocacy Groups
www.youtube.com/@cor2edthehe...
#MedSky
ESMO 2025: Gastric and gastroesophageal cancer insights for clinical practice
On-demand video and slides from an Experts Knowledge Share event
▶️ cor2ed.com/gi-connect/p...
Supported by an Independent Educational Grant from Amgen
#MedEd #MedicalEducation
#Hypophosphatasia across 3 generations – can you help make their dream a reality?
▶️ unifyrare.com/en/closing-t...
Programme initiated and funded by Alexion, AstraZeneca Rare Disease. Brought to you by COR2ED Medical Affairs. Intended for healthcare professionals only. M/GL/Med HPP/0099 | Dec 2025
Closing the Gap in HPP Care 2025
webapp.spotme.com/login/alexio...
📅 2 & 4 December | Live sessions
Initiated and funded by Alexion, AstraZeneca Rare Disease and brought to you in collaboration with COR2ED Medical Affairs. Intended for healthcare professionals only. M/GL/Med HPP/0096 | Nov 2025
Today is #WorldHPPDay
#Hypophosphatasia (HPP) is a #RareDisease that can impact working, connecting, and living independently
In the video (GL/UNB-H/0096), Suzanne & Amy share their HPP stories 📺
This material has been initiated and funded by Alexion Pharmaceuticals. 10/2025 GL/UNB-H/0095
Rethinking HPP (hypophosphatasia)
➡️ HPP is an inherited disorder that can impact a patient’s ability to work, connect, and live independently
Watch the video (GL/UNB-H/0087) for key facts 📺
This material has been initiated and funded by Alexion Pharmaceuticals. 10/2025 GL/UNB-H/0091
#RareDiseases
Colleagues at #ESMO25 , Join our Collaborators at COR2ED and Dr. Lizzy Smyth straight from Berlin 👉 cor2ed.com/esmo-2025/up...
Dr Smyth will review key studies including MATTERHORN, LEAP-014, and SKYSCRAPER-07 — and discuss whether these results could change clinical practice.
Colleagues at #ESMO25
Dr Herbert Loong shares his perspectives on the latest data on oncogene-addicted non-small cell lung cancer (NSCLC) presented at ESMO 2025. Go to the COR2ED website to watch his video update and download the accompanying slides
cor2ed.com/esmo-2025/on...
Prof. Viktor Grünwald shares his renal cell carcinoma highlights from ESMO 2025 as he reviews the latest data from the LenCabo, KEYMAKER-U03 and CLEAR studies. He also discusses staging of disease with the radiolabelled peptide ([68Ga]Ga-DPI-4452).
cor2ed.com/esmo-2025/re...
Dear Colleagues, Our Collaborators at COR2ED Invite you to watch Highlights from #ESMO25
WATCH HERE 👉 cor2ed.com/esmo-2025/br...
Straight from Berlin, Experts share their views on new data on #BreastCancer & #GynOnc
NOW ON DEMAND
Exploring the role of targeted radiopharmaceutical treatment in NETs
Experts discuss PRRT and emerging strategies in neuroendocrine tumours
📹 Watch the video
Supported by an Independent Educational Grant from ITM
#MedEd #MedSky
How can new clinical trials in radioligand therapy impact clinical practice in #NET treatment strategies?
Find out in this new #MedEd video from medical experts
cor2ed.com/net-connect/...
Supported by an Independent Educational Grant from ITM
@nanets.bsky.social #MedSky #medicaleducation 📷
📢 New #dermatology micro learning!
Improving acne vulgaris with multimodal treatment strategies
>> cor2ed.com/dermatology-...
📺 4-min video, downloadable flashcard & slides, and accredited assessment
Supported by an Independent Educational Grant from Glenmark Pharmaceuticals
#MedSky
🔎 Expert insights on recent #BreastCancer data
Dr Paolo Tarantino discusses data from SERENA-6, ASCENT-04/KEYNOTE-D19 & DESTINY-Breast09 studies presented at #ASCO25
Watch his video & see more ASCO updates
▶️ cor2ed.com/n-connect/pr...
Supported by COR2ED #MedEd #MedSky @ptarantinomd.bsky.social
🚨 Best practices in managing early relapsed/refractory multiple myeloma
3-part video series with expert insights & downloadable slide sets
⬇️
cor2ed.com/lymphoma-mye...
Supported by an Independent Educational Grant from Menarini Stemline Oncology
#MedSky #MedEd #RRMM
➡️Tx strategies for pts w/ advanced #HCC who are ineligible for #immunotherapy or with progression on #IO
👉 cor2ed.com/hcc-connect/...
Endorsed by @digestivecancerseu.bsky.social @bluefaeryliver.bsky.social @aasldnews.bsky.social @europeliver.bsky.social
Supported by an IME Grant from Bayer #meded
Congratulations to the newly elected ESMO Directors & Nomination Committee members!
A special mention to:
👏 GI CONNECT's Dr @lizzysmyth.bsky.social
👏 PRECISION ONCOLOGY CONNECT's Prof. Ulrik Lassen
👏 Prof. Rachel Riechelmann, who has collaborated with NET CONNECT
#MedicalEducation #ESMO #MedSky
📹 Watch the video > cor2ed.com/n-connect/pr...
Video: The evolution of our understanding that led us to rethink #hypophosphatasia (HPP) 💡
w/ Dr Chad Deal
Programme initiated & funded by Alexion Pharmaceuticals. Intended for healthcare professionals only. GL/UNB-H/0074
#MedEd #MedSky #EULAR2025
📣Update from #ASCO25
Expert insights on the latest data: cor2ed.com/n-connect/pr...
#NSCLC #ProstateCancer #GICancer #BreastCancer #OvarianCancer #CervicalCancer
NSCLC update supported by an Independent Educational Grant from Bayer.Other updates supported by COR2ED
#MedEd @lizzysmyth.bsky.social
📹 Watch the video: cor2ed.com/n-connect/pr...
Video: Recognising #hypophosphatasia (HPP)🔍
- Key manifestations
- Common misdiagnoses
w/ Dr Chad Deal
Programme initiated & funded by Alexion Pharmaceuticals. Intended for healthcare professionals only. GL/UNB-H/0074
#MedEd #EULAR2025
📣Highlights from #ESMO Breast Cancer 2025 Satellite Symposium
Experts discuss treatment strategies/sequencing after ET+CDK4/6i for ER+/HER2- metastatic #breastcancer
cor2ed.com/n-connect/pr...
This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
Chemotherapy strategies in mPDAC
➡️How to choose & optimise the different chemotherapeutic options at 1st & 2nd line
w/ Profs. Efrat Dotan & Shubham Pant
📹 Watch the video/listen on Spotify/Apple cor2ed.com/gi-connect/p...
Supported by an Independent Educational Grant from Ipsen USA
#MedEd
